Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NuvaRing Acceptability and Adherence in Kenyan Women
NCT02529683Completed
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Apr 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of etonogestrel + ethinyl estradiol in contraception, sponsored by Centers for Disease Control and Prevention. Primary endpoints: Participant-reported Acceptability at 6 months, Biological measures of Adherence at 6 months and 3 more. Started Apr 2014; status: completed.
02
Drugs
etonogestrel + ethinyl estradiol
03
Conditions
contraception
Beyond the preview
Go deeper on NCT02529683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02529683.